<?xml version="1.0"?>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title>Estimating Chikungunya prevalence in La R&#xE9;union Island outbreak by serosurveys : two methods for two critical times of the epidemic</dc:title>
  <dc:creator>G&#xE9;rardin, P.</dc:creator>
  <dc:creator>Guernier, V.</dc:creator>
  <dc:creator>Perrau, J.</dc:creator>
  <dc:creator>Fianu, A.</dc:creator>
  <dc:creator>Le Roux, K.</dc:creator>
  <dc:creator>Grivard, P.</dc:creator>
  <dc:creator>Michault, A.</dc:creator>
  <dc:creator>/de Lamballerie, Xavier</dc:creator>
  <dc:creator>Flahault, A.</dc:creator>
  <dc:creator>Favier, F.</dc:creator>
  <dc:description>Background: Chikungunya virus (CHIKV) caused a major two-wave seventeen-month-long outbreak in La Reunion Island in 2005-2006. The aim of this study was to refine clinical estimates provided by a regional surveillance-system using a two-stage serological assessment as gold standard. Methods: Two serosurveys were implemented: first, a rapid survey using stored sera of pregnant women, in order to assess the attack rate at the epidemic upsurge (s1, February 2006; n = 888); second, a population-based survey among a random sample of the community, to assess the herd immunity in the post-epidemic era (s2, October 2006; n = 2442). Sera were screened for anti-CHIKV specific antibodies (IgM and IgG in s1, IgG only in s2) using enzyme-linked immunosorbent assays. Seroprevalence rates were compared to clinical estimates of attack rates. Results: In s1, 18.2% of the pregnant women were tested positive for CHIKV specific antibodies (13.8% for both IgM and IgG, 4.3% for IgM, 0.1% for IgG only) which provided a congruent estimate with the 16.5% attack rate calculated from the surveillance-system. In s2, the seroprevalence in community was estimated to 38.2% (95% CI, 35.9 to 40.6%). Extrapolations of seroprevalence rates led to estimate, at 143,000 and at 300,000 (95% CI, 283,000 to 320,000), the number of people infected in s1 and in s2, respectively. In comparison, the surveillance-system estimated at 130,000 and 266,000 the number of people infected for the same periods. Conclusion: A rapid serosurvey in pregnant women can be helpful to assess the attack rate when large seroprevalence studies cannot be done. On the other hand, a population-based serosurvey is useful to refine the estimate when clinical diagnosis underestimates it. Our findings give valuable insights to assess the herd immunity along the course of epidemics.</dc:description>
  <dc:date>2008</dc:date>
  <dc:type>text</dc:type>
  <dc:identifier>https://www.documentation.ird.fr/hor/fdi:010048276</dc:identifier>
  <dc:identifier>fdi:010048276</dc:identifier>
  <dc:identifier>G&#xE9;rardin P., Guernier V., Perrau J., Fianu A., Le Roux K., Grivard P., Michault A., de Lamballerie Xavier, Flahault A., Favier F.. Estimating Chikungunya prevalence in La R&#xE9;union Island outbreak by serosurveys : two methods for two critical times of the epidemic. 2008, 8,  99</dc:identifier>
  <dc:language>EN</dc:language>
</oai_dc:dc>
